Table 1.
Prevalence of HTN and HTN Outcomes by Gender in Adults With and Without VWD.
| All Adult Discharges | Adult Male Discharges | Adult Female Discharges | |||||||
|---|---|---|---|---|---|---|---|---|---|
| VWD | No VWD | P Valuea | VWD | No VWD | P Valuea | VWD | No VWD | P Valuea | |
| Percent or Mean (SE) | Percent or Mean (SE) | Percent or Mean (SE) | Percent or Mean (SE) | Percent or Mean (SE) | Percent or Mean (SE) | ||||
| No. of adult admissions, raw (weighted) | 7556 (37 415) | 19 918 970 (98 686 824) | – | 1857 (9187) | 8 026 805 (39 817 077) | – | 5697 (28 220) | 11 870 458 (58 764 092) | – |
| No. HTN, raw (weighted) | 2823 (13 974) | 9 844 345 (48 751 806) | – | 882 (4364) | 4 527 975 (22 422 452) | – | 1940 (9606) | 5 315 113 (26 323 356) | – |
| % HTN | 37.35 | 49.4 | <.0001 | 47.5 | 56.31 | <.0001 | 34.04 | 44.79 | <.0001 |
| Age (years) | 49.67 (0.23) | 57.30 (0.005) | <.0001 | 54.88 (0.48) | 60.37 (0.01) | <.0001 | 47.97 (0.26) | 55.24 (0.01) | <.0001 |
| Sex (male) | 24.56 | 40.39 | <.0001 | – | – | – | – | – | – |
| Race/ethnicity | |||||||||
| White | 82.23 | 68.35 | <.0001 | 82.44 | 70.75 | <.0001 | 82.16 | 66.72 | <.0001 |
| Black | 6.79 | 15.03 | 6.76 | 14.59 | 6.8 | 15.33 | |||
| Hispanic | 6.42 | 10.57 | 6.78 | 9.05 | 6.3 | 11.6 | |||
| Asian | 1.64 | 2.27 | 1.20 | 1.9 | 1.79 | 2.52 | |||
| Native American | 0.47 | 0.68 | 0.44 | 0.65 | 0.48 | 0.7 | |||
| Other | 2.44 | 3.11 | 2.38 | 3.07 | 2.46 | 3.13 | |||
| Admission for HTN | 0.37 | 0.93 | <.0001 | 0.54 | 1.05 | .0344 | 0.31 | 0.85 | <.0001 |
| Admission for CVD | 1.40 | 2.19 | <.0001 | 2.83 | 3.45 | .1427 | 0.94 | 1.34 | .0081 |
| Admission for CKD | 0.20 | 0.51 | .0001 | 0.44 | 0.67 | .2446 | 0.12 | 0.41 | .0004 |
| Length of stay (days) | 4.60 (0.07) | 4.77 (0.001) | <.0001 | 5.43 (0.17) | 5.22 (0.003) | <.0001 | 4.34 (0.07) | 4.47 (0.002) | <.0001 |
| Inpatient mortality | 1.34 | 2.20 | <.0001 | 2.40 | 2.75 | .3597 | 0.99 | 1.82 | <.0001 |
| HTN risk factors | |||||||||
| Hyperlipidemia | 17.27 | 25.59 | <.0001 | 25.22 | 30.94 | <.0001 | 14.69 | 22.01 | <.0001 |
| Diabetes | 13.50 | 23.41 | <.0001 | 17.92 | 27.65 | <.0001 | 12.06 | 20.58 | <.0001 |
| Obesity | 9.22 | 9.98 | .028 | 7.13 | 8.96 | .0057 | 9.89 | 10.69 | .0518 |
| Smoke | 6.42 | 8.38 | <.0001 | 9.47 | 11.45 | .0074 | 5.43 | 6.3 | .007 |
| Hepatitis C | 3.75 | 1.79 | <.0001 | 6.24 | 2.78 | <.0001 | 2.94 | 1.13 | <.0001 |
| Liver Disease | 1.00 | 0.79 | .0458 | 1.37 | 0.93 | .0528 | 0.87 | 0.7 | .1077 |
| HIV | 0.39 | 0.76 | .0001 | 1.16 | 1.25 | .7209 | 0.14 | 0.44 | .0005 |
| HTN-associated outcomes | |||||||||
| ASHD | 10.92 | 19.52 | <.0001 | 19.37 | 27.72 | <.0001 | 8.18 | 14 | <.0001 |
| Angina | 0.50 | 0.80 | .0031 | 0.85 | 1.07 | .3524 | 0.38 | 0.62 | .0241 |
| MI | 1.99 | 4.58 | <.0001 | 2.70 | 6.68 | <.0001 | 1.76 | 3.17 | <.0001 |
| Ischemic stroke | 1.55 | 2.97 | <.0001 | 1.87 | 3.62 | <.0001 | 1.45 | 2.54 | <.0001 |
| Hemorrhagic stroke | 0.60 | 0.57 | .6705 | 1.23 | 0.72 | .0094 | 0.39 | 0.46 | .3926 |
| Renal failure | 5.57 | 12.32 | <.0001 | 9.42 | 16.08 | <.0001 | 4.32 | 9.8 | <.0001 |
| Hematuria | 1.34 | 1.07 | .0298 | 2.70 | 1.76 | .0024 | 0.89 | 0.61 | .0074 |
| Proteinuria | 0.20 | 0.31 | .0861 | 0.06 | 0.31 | .0754 | 0.24 | 0.31 | .3632 |
Abbreviations: ASHD, atherosclerotic heart disease; CKD, chronic kidney disease; CVD, cardiovascular disease; HTN, hypertension; MI, myocardial infarction; SE, standard error; VWD, von Willebrand disease.
aRao-Scott χ2 test.